ARK Genomic Revolution ETF (BATS: ARKG)
Ticker | Name | Share % | |
---|---|---|---|
TWST | Twist Bioscience Corp. | 6.98% | |
CDNA | Caredx | 3.97% | |
SM | Crispr Therapeutics Ag | 8.52% | |
RXRX | Recursion Pharmaceuticals, Inc. | 5.45% | |
IONS | Ionis Pharmaceuticals Inc | 4.88% | |
NTLA | Intellia Therapeutics | 4.74% | |
BEAM | Beam Therapeutics Inc | 4.09% | |
SDGR | Schrodinger, Inc. | 4.73% | |
ADPT | Adaptive Biotechnologies Corporation | 4.76% | |
TXG | 10X Genomics Inc | 3.61% | |
TEM | Tempus Pe | 9.57% | |
NTRA | Natera Inc | 6.12% | |
GH | Guardant Health Inc. | 6.11% | |
VCYT | Veracyte Inc (vcyt) | 3.57% | |
PSNL | Personalis Inc Com | 3.67% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
ARKG suit un style d'investissement Small Cap Growth.
Les principales positions de ARKG incluent : TWST (6.98%), CDNA (3.97%), SM (8.52%), RXRX (5.45%), IONS (4.88%). Il s'agit des plus grandes positions dans le portefeuille de l'ETF.
Les données du volume moyen quotidien pour ARKG ne sont actuellement pas disponibles.